Botulinum toxin type A in the treatment of painful adductor muscle contracture after total hip arthroplasty

Orthopedics

Volumn 32, Issue 10, 2009, Pages 774-776

  Santamato, Andrea ^a   Ranieri, Maurizio ^b   Panza, Francesco ^b   Solfrizzi, Vincenzo ^b   Frisardi, Vincenza ^b   Lapenna, Luisa Maria ^c   Moretti, Biagio ^b   Fiore, Pietro ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c OSMAIRM Rehabilitation Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN A; GABAPENTIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADDUCTION; ADULT; ARTICLE; CASE REPORT; FEMALE; FOLLOW UP; GAIT; HARRIS HIP SCORE; HUMAN; MUSCLE CONTRACTURE; MUSCLE STRENGTH; PAINFUL ADDUCTOR MUSCLE CONTRACTURE; QUADRICEPS FEMORIS MUSCLE; RANGE OF MOTION; RATING SCALE; REHABILITATION CARE; TOTAL HIP PROSTHESIS; VISUAL ANALOG SCALE;

EID: 70450200099     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20090818-29     Document Type: Article

References (16)

1. Della Valle CJ, Rafii M, Jaffe WL. Iliopsoas tendinitis after total hip arthroplasty. J Arthroplasty. 2001; 16(7):923-926. (Pubitemid 32971606)
2. Cheung YM, Gupte CM, Beverly MJ. Iliopsoas bursitis following total hip replacement. Arch Orthop Trauma Surg. 2004; 124(10):720-723 (Pubitemid 40057901)
3. Seyler TM, Smith BP, Marker DR, et al. Botulinum neurotoxin as a therapeutic modality in orthopaedic surgery: more than twenty years of experience. J Bone Joint Surg Am. 2008; 90(suppl 4):133-145.
4. Medical Research Council. Aids to the Examination of the Peripheral Nervous System. London, United Kingdom: Her Majesty's Stationery Office; 1975. Memorandum No. 45.
5. Price DD, Bush FM, Long S, Harkins SW. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain. 1994; 56(2):217-226. (Pubitemid 24067851)
6. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969; 51(4):737-755.
7. Matos M, Amstutz H, Machleder H. Ischemia of the lower extremity after total hip replacement. J Bone Joint Surg Am. 1979; 61(1):24-27.
8. Oh I, Hardacre J. Fatigue fracture of the inferior pubic ramus following total hip replacement for congenital hip dislocation. Clin Orthop Relat Res. 1980; (147):154-156. (Pubitemid 10098149)
9. Davis KE, Ritter MA, Berend ME, Meding JB. The importance of range of motion after total hip arthroplasty. Clin Orthop Relat Res. 2007; (465):180-184. (Pubitemid 350306513)
10. Wissel J, Ward AB, Erztgaard P, et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med. 2009; 41(1):13-25.
11. Hallett M, Benecke R, Blitzer A, Comella CL. Treatment of focal dystonias with botulinum neurotoxin. Toxicon. 2008; 54(5):628-633.
12. Fish DE, Chang WS. Treatment of iliopsoas tendinitis after a left total hip arthroplasty with botulinum toxin type A. Pain Physician. 2007; 10(4):565-571
13. Bertoni M, Castagna A, Baricich A, Berti G, Lazzaretti S, Morandi C. Administration of type A botulinum toxin after total hip replacement. Eur J Phys Rehabil Med. 2008; 44(4):461-465.
14. Khot A, Sloan S, Desai S, Harvey A, Wolfe R, Graham HK. Adductor release and chemodenervation in children with cerebral palsy: a pilot study in 16 children. J Child Orthop. 2008; 2(4):293-1239
15. Mall V, Heinen F, Siebel A, et al. Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study. Dev Med Child Neurol. 2006; 48(1):10-13. (Pubitemid 43124451)
16. Yang EJ, Rha DW, Kim HW, Park ES. Comparison of botulinum toxin type A injection and soft-tissue surgery to treat hip subluxation in children with cerebral palsy. Arch Phys Med Rehabil. 2008; 89(11):2108-2113.